Castor notes that its drug development timelines are still sluggish and that clinical development stage movement is not yet seeing real movement.
Published
Signal category
Research & Knowledge
Quote
“Our drug development timelines are still sluggish. While everyone's excited, we're not yet seeing real movement when it comes to the clinical development stage.”
— Derk Arts, MD PhD|Castor team
Company
Castor
Real-world ready. Remote-first. AI-powered - Our technology is designed to ease the load and deliver results.
- Industry
- Software Development
- Location
- New York, US
- Company size
- 310 employees
At Castor, we believe in the power of clinical research and the power of technology. And we know that together, these forces can help extend human healthspan. To achieve this reality, we must make patient-centered clinical trials a possibility for everyone, anywhere in the world. That's why we are using technology to capture the world's research data and optimize each activity of a clinical trial. From recruitment to monitoring, our modular clinical trial platform makes it easier to design and deploy trials, enroll and engage patients, collect data and analyze results. Each module can be used individually or in unison with others, providing the ability to customize each solution to fit your needs, and grow at your own pace. That’s delightful for patients, effortless for study teams, risk-free for sponsors.
Founded 2011